Cervical Screening & HPV Vaccine
What is Cervical Screening & HPV Vaccination?
Cervical cancer is almost entirely preventable through proactive vaccination and periodic clinical screening. Over 99% of cervical malignancies originate from chronic, high-risk Human Papillomavirus (HPV) infections. By combining periodic Pap smear cytology with molecular HPV DNA co-testing and HPV immunization, women can lower their lifetime risk of cervical cancer by over 90%.
At Dr. Deepika Lalwani (Nagwani)'s Clinic in New Kalyani Nagar & Wadgaon Sheri, Pune, we provide a comfortable, supportive environment for cervical cancer prevention. Led by Dr. Deepika Lalwani (MBBS, DGO Mumbai) with over 10+ years of dedicated clinical experience, our practice offers DCGI-approved HPV vaccines (Gardasil 9 and Cervavac) alongside gentle cytology swabs.
All vaccinations and Pap smears are personally conducted by Dr. Deepika Lalwani strictly by prior appointment, ensuring complete privacy, pristine sterilization, and compassionate preventive care.
Gardasil 9 vs. Cervavac: HPV Vaccine Comparison
We offer both globally established vaccines and India's indigenous cervical cancer vaccine to provide flexible, evidence-based preventive protection.
Gardasil 9 (Nonavalent)
Broadest Global Coverage • 9 Strains
Protects against 9 strains (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58).
Extensive global clinical track record across 100+ countries over a decade.
Approved for females and males aged 9 to 45 years against cancer and warts.
Manufactured by MSD (Merck & Co., USA), WHO pre-qualified worldwide.
Cervavac (Quadrivalent)
Indigenous Innovation • High Efficacy
Protects against 4 primary high-risk strains (HPV 6, 11, 16, 18).
Robust antibody response demonstrated specifically in Indian clinical trials.
Approved for girls and young women aged 9 to 26 years across India.
Developed by Serum Institute of India (Pune), offering affordable protection.
Comprehensive Cervical Screening Programs
Early detection is the most powerful defense against cervical cellular changes, identifying risks years before tumors form.
Liquid-Based Cytology (LBC)
High-precision automated cytology screening capturing a thin layer of cervical cells to detect pre-cancerous dysplasia years before tumor progression.
High-Risk HPV DNA PCR Testing
Molecular PCR assays identifying high-risk oncogenic HPV viral genotypes (16, 18, 31, 33, 45, 52, 58) directly responsible for cervical lesions.
Diagnostic Colposcopy Exam
High-magnification optical inspection of the transformation zone with acetic acid staining for patients with abnormal or ASC-US screening reports.
Annual Preventive Gynae Audit
Comprehensive pelvic wellness checks evaluating external vulvar health, vaginal microbiome balance, and cervical epithelial integrity.
Recommended HPV Vaccination & Screening Schedules
Adhering to age-specific vaccination and co-testing intervals delivers maximum lifetime preventive protection.
Adolescent Schedule (Ages 9 to 14)
Requires a 2-dose regimen (0 and 6 months). Administering the vaccine at this age generates the strongest, lifelong neutralizing antibody titers.
Catch-up Adult Schedule (Ages 15 to 45)
Requires a 3-dose regimen (0, 2, and 6 months). Highly recommended for active adult women to protect against unexposed oncogenic HPV strains.
Lifelong Co-Testing Protocol
For women aged 30+, combining Pap smear cytology with HPV DNA molecular testing every 5 years guarantees complete preventive safety.
The Clinical Screening & Vaccination Journey
Structured clinical protocols with rigorous cold-chain storage to guarantee comfort, safety, and vaccine potency.
Every treatment and procedure at our clinic is performed with the highest standards of safety, compassion, and clinical expertise. Dr. Deepika Lalwani ensures each step of your journey is carefully monitored and optimized for the best possible outcomes.
Expert Guidance
From your initial consultation through recovery, our dedicated team is here to support you with personalized care, ensuring your comfort and peace of mind at every stage.
Step 1: Clinical Assessment & Vaccine Selection
Reviewing age, previous sexual activity, and screening history to recommend either Gardasil 9 or Cervavac according to national guidelines.
Step 2: Gentle Pap or HPV Swab Collection
If due for periodic screening, a quick and painless cervical swab is taken using specialized soft cytobrushes to ensure maximum comfort.
Step 3: Sterile Intramuscular Vaccine Administration
Administering the approved HPV vaccine as a gentle, sterile deltoid intramuscular injection with minimal post-injection tenderness.
Step 4: Digital Dose Reminders & Follow-Up
Logging the immunization schedule in our clinic system and dispatching automated reminders for subsequent catch-up doses.
Why Choose Dr. Deepika Lalwani's Clinic for HPV Care?
- Direct Gynecologist Specimen CollectionCytological swabs are taken directly by Dr. Deepika Lalwani (MBBS, DGO Mumbai), avoiding sample inadequacy and errors.
- Guaranteed Cold-Chain Vaccine PotencyDirect access to authentic DCGI-approved Cervavac and Gardasil 9 maintained under continuous temperature monitoring.
- Dedicated Prior-Appointment ScheduleAll appointments are scheduled privately in New Kalyani Nagar with zero waiting queues and complete medical confidentiality.
Google Rating
Based on 105+ Reviews
Frequently Asked Questions
In Pune, Cervavac (Serum Institute of India's quadrivalent HPV vaccine) typically costs approximately ₹2,200 to ₹2,500 per dose. Gardasil 9 (MSD's imported nonavalent HPV vaccine covering 9 oncogenic strains) costs approximately ₹10,500 to ₹11,500 per dose. Liquid-Based Cytology (Pap Smear) ranges from ₹1,500 to ₹2,200, while combined Pap + HPV DNA molecular co-testing ranges from ₹3,200 to ₹4,800.
The HPV vaccine protects against oncogenic Human Papillomavirus strains that cause over 90% of cervical cancers, vulvar cancers, and genital warts. It is recommended for girls and boys starting from age 9 up to adult women aged 45.
Gardasil 9 (MSD) is an imported nonavalent vaccine protecting against 9 HPV strains (6, 11, 16, 18, 31, 33, 45, 52, 58). Cervavac (Serum Institute of India) is an indigenous quadrivalent vaccine covering the 4 primary strains (6, 11, 16, 18) responsible for the majority of Indian cervical cancer cases, offering an affordable alternative.
Yes, absolutely. Even if a woman has been exposed to one strain of HPV, the vaccine still provides powerful immunity against the remaining high-risk oncogenic strains included in the formulation.
Yes. While the vaccine covers the most dangerous cancer-causing strains, it does not protect against 100% of all rare HPV genotypes. Continuing routine Pap smears or HPV DNA tests every 3 to 5 years ensures comprehensive protection.
Visits are scheduled strictly by prior appointment in our New Kalyani Nagar clinic during dedicated morning and evening hours, ensuring cold-chain vaccine integrity, zero waiting room crowds, and dedicated clinical time with Dr. Deepika Lalwani.